ZEB1 and colonic neoplasm: Furthermore, our findings, revealing the ability of the ETAR/ZEB1 axis to control EMT-associated GSDME functions in breast and colon cancer cells, suggest exploring ETAR blockade to counteract nuclear transcriptional activities and metastatic progression in other tumor histotypes overexpressing ETAR.